Patients who develop both hyperthyroidism and extrathyroidal (non-thyroid) Graves' symptoms generally develop hyperthyroidism first. The eye and skin disorders then develop within eighteen months of the onset of hyperthyroidism. However, in a small number of patients, extrathyroidal symptoms develop first.
PTM occurs in about 2% to 3% of GD patients and it may also rarely occur in patients with Hashimoto's thyroiditis. Approximately 7% of patients with PTM go on to develop acropachy. The usual order of development is hyperthyroidism first, then PTM, and later acropachy. Acropachy may develop up to 40 years after the initial emergence of hyperthyroidism. PTM is a skin disorder more accurately called localized myxedema. Unlike rashes, the disorder is confined to a specific dermal or skin area, without spreading.
Pretibial refers to the lower front surface area of the leg, including the skin covering the foot and shin. Although myxedema is a synonym for hypothyroidism, pretibial myxedema is not at all related to hypothyroidism. Rather, used in this sense, myxedema refers to the swollen tissue and excess mucin content. Mucin is a gelatinous substance which accumulates in the skin causing a waterlogged appearance.
Besides the pretibial area, the localized myxedema of Graves’ disease may affect the back, arms and shoulders, and recent studies indicate that it may develop in sites of scarring or trauma. One recent study describes a patient developing localized myxedema on the thigh at the site of a donor skin graft. This was the initial presentation or earliest symptoms of Graves’ disease for this patient. Hyperthyroidism developed later. (J An Acad Dermatol 1998 Nov; 39(5) Part 2:846).
Go To Page: 1 2